Haisco Pharmaceutical's controlling shareholder unpledges some shares

Haisco Pharmaceutical Group Co., Ltd. has confirmed that its controlling shareholder and de facto controller, Wang Junmin, has unpledged a portion of his shares in the company. The unpledging involved 7.5m shares, representing 1.88% of his total holdings and 0.67% of the company's total share capital. The pledge was initiated on November 22, 2023, and officially released on November 21, 2025, due to the expiration of the pledge period. The shares were originally pledged to Ping An Securities Co., Ltd.

Following this transaction, Wang Junmin's total pledged shares amount to 634.4m, which constitutes 15.88% of his overall shareholding and 5.66% of Haisco Pharmaceutical Group's total share capital. All of Wang Junmin's pledged shares are not subject to any restricted or frozen conditions.

The company's announcement also includes details for Shen Ping, whose 39.25m shares remain unpledged. The cumulative pledged shares for the controlling shareholder and related parties now stand at 634.4m, representing 14.46% of their total holdings and 5.66% of the company's total share capital, with no pledged shares under restricted or frozen status.